# EDGAR Filing Document

**Accession Number:** 0001603707
**File Stem:** 0001575872-25-000596
**Filing Date:** 2025-9
**Character Count:** 81072
**Document Hash:** 746fccea854ffd9a16481d4dda7099ce
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001575872-25-000596.hdr.sgml**: 20250925

**ACCESSION NUMBER**: 0001575872-25-000596

**CONFORMED SUBMISSION TYPE**: 1-SA

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250925

**DATE AS OF CHANGE**: 20250925

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TriplePulse, Inc.
- **CENTRAL INDEX KEY:** 0001603707
- **STANDARD INDUSTRIAL CLASSIFICATION:** FOOD & KINDRED PRODUCTS [2000]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 461514058
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 1-SA
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 24R-00383
- **FILM NUMBER:** 251340234

**BUSINESS ADDRESS:**
- **STREET 1:** 1316 3RD ST PROMENADE
- **STREET 2:** SUITE B2
- **CITY:** SANTA MONICA
- **STATE:** CA
- **ZIP:** 90401
- **BUSINESS PHONE:** (424) 256-9133

**MAIL ADDRESS:**
- **STREET 1:** 3103 NEILSON WAY
- **STREET 2:** #D
- **CITY:** SANTA MONICA
- **STATE:** CA

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 1-SA**

⌧ **SEMIANNUAL REPORT PURSUANT TO REGULATION A**

**or**

◻ **SPECIAL FINANCIAL REPORT PURSUANT TO REGULATION A**

For the fiscal semiannual period ended: <u>June 30, 2025</u>

**TriplePulse, Inc.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware** | **46-1514058** |
| (State or other jurisdiction of incorporation or<br> organization) | (I.R.S. Employer Identification No.) |

---

**1401 21st St, Ste R**

**Sacramento, CA 95811**

(Mailing Address of principal executive offices)

**(650) 241-8372**

Issuer's telephone number, including area code

*In this report, the terms "our," "we," "us" or "the company" refers to TriplePulse, Inc.*

This report may contain forward-looking statements and information relating to, among other things, the company, its business plan and strategy, and its industry. These forward-looking statements are based on the beliefs of, assumptions made by, and information currently available to the company's management. When used in this report, the words "estimate," "project," "believe," "anticipate," "intend," "expect" and similar expressions are intended to identify forward-looking statements, which constitute forward looking statements. These statements reflect management's current views with respect to future events and are subject to risks and uncertainties that could cause the company's actual results to differ materially from those contained in the forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. The company does not undertake any obligation to revise or update these forward-looking statements to reflect events or circumstances after such date or to reflect the occurrence.

**Item 1. Management's Discussion and Analysis of Financial Condition and Results of Operations**

The following discussion of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes included in this report. The following discussion contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Unless otherwise indicated, the latest results discussed below are as of June 30, 2025.

The following discussion of our financial condition and results of operations for the six-month period ended June 30, 2025, compared to the same period in 2024. This discussion should be read in conjunction with our consolidated financial statements and the related notes.

**Overview**

The Company produces and sells high function food, beverage, and nutrition products to mainstream consumers that deliver meaningful and measurable outcomes. We believe that consumers consider our brand, TruBrain, as one of the most premium, trusted brands in cognitive and athletic performance - one that produces positive results for consumers and can be measured by biomarkers. Aside from superior products, we believe that our brand reputation sets us apart from the competition. Our direct-to-consumer ("DTC") channel consists of online subscription sales of products produced by the Company.

We seek to reach our target customer audience through a multi-faceted marketing strategy that is designed to integrate our brand image with the lifestyles we represent. We pursue a marketing strategy which leverages our fans, ambassadors, digital marketing and social media, and a variety of grassroots initiatives. We also plan to continue to explore how we can complement and amplify our community-based initiatives with brand-building activity. We are continuously looking to partner and build meaningful relationships with social media influencers to produce high-quality achievement-focused content. We believe this approach offers an opportunity for our customers to develop a strong identity with our brands and culture.

**Results of Operations**

***Summary of Results of Operations for the Six months ended June 30, 2025 and 2024:***

*Net Revenues*

Net revenues for the six months ended June 30, 2025 were $1,280,692 compared to $1,029,944 for the six months ended June 30, 2024, an increase of 24%. The increase in revenue was primarily due to increased new customer acquisition spend in response to a more efficient advertising environment for obtaining new, loyal customers.

*Cost of Goods Sold*

Our cost of goods sold for the six months ended June 30, 2025 was $403,015, compared to $316,582 the six months ended June 30, 2024. The increase in cost of goods sold is primarily related to fluctuating product gross margins and increased sales of our product offerings. Our gross margin may in the future fluctuate from period to period based on a number of factors, including cost of purchased components, discounts and promotional activity, the mix of products, and services we sell and the mix of channels through which we sell our products. We have historically experienced that gross margin, by product, tends to increase over time as we realize cost efficiencies as a result of economies of scale and sourcing strategies. In addition, our ability to continue to reduce the cost of our products, decreasing return rates, and controlling shipping costs are critical to increasing our gross margin over the long-term.

*Operating Expenses*

Total operating expenses for the six months ended June 30, 2025 was $780,042, compared to $633,758 for the six months ended June 30, 2024, an increase of 23%.

Marketing and advertising costs represented $226,914 and $176,741, respectively. Advertising costs increased year-over-year, as we continue to spend behind our highest performing new customer acquisition strategies, while remaining efficient in digital media spend to attract the right loyal mix of customers.

Wage expenses represented $145,980 and $136,719 respectively, an increase of 6%. This increase is mostly attributed to the efficiency of our core operations team to support our core direct-to-consumer ("DTC") sales channel.

General and administrative expenses increased $86,850, or 27%, from $320,298 for the six months ended June 30, 2024 to $407,148 for the six months ended June 30, 2025, largely due to the increase in insurance costs, consulting and professional fees.

Interest expense was $3,626 for the six months ended June 30, 2025 compared to $3,656 for the six months ended June 30, 2024.

*Net Income*

Our net income for the six months ended June 30, 2025 was $94,009, compared to a net income of $75,948 for the six months ended June 30, 2024. We believe our investments in process and operational discipline will set us up well for sustainable expansion in future years.

**Liquidity and Capital Resources**

As of June 30, 2025, our current cash and cash equivalents were $1,390,605, compared to $1,524,584 as of December 31, 2024. Net inventory as of June 30, 2025 was $520,028. As of June 30, 2025, we had total liabilities in the amount of $263,779. We currently anticipate that cash flow from operations will continue to provide a significant source of our operating needs. We expect that our liquidity needs for the next twelve months will be met by continued use of operating cash flows and funds raised in our Equity Crowdfunding offering. We believe that we will be able to continue to operate our business for the foreseeable future.

**Debt**

On July 8, 2020, the Company entered into a loan with Coastal Community Bank, guaranteed by the U.S. Small Business Administration (SBA), in the amount of $150,000, with monthly payments beginning July 8, 2021, in the amount of $751 per month for a term of thirty (30) years, with an interest rate of 3.75% per annum.

On July 30, 2021, the U.S. Small Business Administration amended the loan and advanced an additional $45,000, increasing the principal balance to $195,000. Monthly payments beginning January 2023 are $998 per month for a term of thirty (30) years, with an interest rate of 3.75% per annum.

At June 30, 2025 and December 31, 2024 the outstanding balance on this note was $195,000 and $195,000, respectively.

**Trend Information**

Our primary goal is to attract and retain loyal customers in our DTC sales channel. As we add customers, we will be able to grow our brand. Sales trends for the six months ended June 30, 2025 showed strong demand across all of TruBrain's Offerings. We continue to find media channels to advertise our products and acquire new customers. We've been able to organically increase our wholesale sales channel, led by Faire Marketplace.

The cognitive nutrition industry is a sizable market in the United States. We believe TruBrain is one of the few cognitive nutrition brands that is connecting with the discerning and savvy consumers and that should lead to a significant and expanding market opportunity.

**Item 2. Other Information**

None.

**Item 3. Financial Statements**

**TRIPLEPULSE, INC.**

**FINANCIAL STATEMENTS**

**INDEX TO FINANCIAL STATEMENTS**

---

| | |
|:---|:---|
|  | Pages |
| [Balance Sheets as of June 30, 2025 and December 31, 2024](#a_001) | [6](#a_001) |
| [Statements of Operations for the six months ended June 30, 2025 and 2024](#a_002) | [7](#a_002) |
| [Statements of Changes in Stockholders' Equity for the six months ended June 30, 2025 and for the year ended December 31, 2024](#a_003) | [8](#a_003) |
| [Statements of Cash Flows for the six months ended June 30, 2025 and 2024](#a_004) | [9](#a_004) |
| [Notes to the Financial Statements](#a_005) | [10](#a_005) |

---

**TriplePulse, Inc.**

**dba TruBrain**

Balance Sheets

---

| | | |
|:---|:---|:---|
|  | June 30, <br>2025 <br>(unaudited) | December 31, <br>2024 |
| Assets |  |  |
| Current assets |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $1390605 | $1524584 |
| &nbsp;&nbsp;&nbsp;Inventories | 520028 | 452040 |
| &nbsp;&nbsp;&nbsp;Prepaid and other assets | 159462 | 159462 |
| Total current assets | 2070095 | 2136086 |
| Right of use asset | - | 19910 |
| Total assets | $2070095 | $2155996 |
| Liabilities and stockholders' equity |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | $44473 | $200606 |
| &nbsp;&nbsp;&nbsp;Accrued interest | 7276 | 6643 |
| &nbsp;&nbsp;&nbsp;Deferred revenue | 17030 | 20320 |
| &nbsp;&nbsp;&nbsp;Lease liability current |  | 21120 |
| Total current liabilities | 68779 | 248689 |
| Long term liabilities |  |  |
| &nbsp;&nbsp;&nbsp;SBA note payable | 195000 | 195000 |
| Total long-term liabilities | 195000 | 195000 |
| Total liabilities | 263779 | 443689 |
| Commitments and contingent liabilities (Note 5) |  |  |
| Stockholders' equity |  |  |
| &nbsp;&nbsp;&nbsp;Preferred stock Series A, 66,666 authorized, par value $0.0001, and 66,666 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively | 7 | 7 |
| &nbsp;&nbsp;&nbsp;Preferred stock Series B, 43,750 authorized, par value $0.0001, and 41,667 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively | 4 | 4 |
| &nbsp;&nbsp;&nbsp;Common Stock, 100,000,000 authorized, par value $0.0001, 64,713,902 and 64,438,818 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively | 6331 | 6331 |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital | 3255117 | 3255117 |
| &nbsp;&nbsp;&nbsp;Shares to be issued |  |  |
| &nbsp;&nbsp;&nbsp;Accumulated deficit | (1455143) | (1549152) |
| Total stockholders' equity | 1806016 | 1712307 |
| Total liabilities and stockholders' equity | $2070095 | $2155996 |

---

The accompanying notes are an integral part of these financial statements

**TriplePulse, Inc.**

**dba TruBrain**

Statements of operations

For the six months ended June 30,

(unaudited)

---

| | | |
|:---|:---|:---|
|  | 2025 | 2024 |
| Revenue | $1280692 | $1029944 |
| Cost of goods sold | 403015 | 316582 |
| Gross profit | 877677 | 713362 |
| Selling, general, and administrative expenses |  |  |
| Marketing and advertising | 226914 | 176741 |
| Wages | 145980 | 136719 |
| General and administrative expenses | 407148 | 320298 |
| Total Expenses | 780042 | 633758 |
| Income from operations | 97635 | 73074 |
| Other expenses |  |  |
| Interest expense | (3626) | (3656) |
| Total other expenses | (3626) | (3656) |
| Income before taxes | 94009 | 75948 |
| Provision for income taxes |  |  |
| Net Income | $94009 | $75948 |
| Net Income per share - basic and diluted | $0.00 | $0.00 |
| Weighted average number of common shares outstanding - basic and diluted | 64713902 | 64619283 |
| Net Income per share - diluted | $0.00 | $0.00 |
| Weighted average number of common shares outstanding - diluted | 70243452 | 64831766 |

---

The accompanying notes are an integral part of these financial statements

**TriplePulse, Inc. dba TruBrain**

Statements of changes in stockholders' equity

For the six months ended June 30, 2025 (unaudited) and for the year ended December 31, 2024

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Preferred Stock | Preferred Stock | Preferred Stock | Preferred Stock | | | | | | |
|  | Series A | Series A | Series B | Series B | Common Stock | Common Stock | | | | |
|  | Shares | Amount | Shares | Amount | Shares | Amount |<br>AdditionalPaid-in<br> Capital |<br>Shares to<br> be Issued |<br>Accumulated<br> Deficit |<br>Total<br> Stockholders'<br> Equity |
| Balance December 31, 2023 | 66666 | $7 | 41667 | $4 | 64438818 | $6303 | $3239459 | $10786 | $(1499898) | $1756661 |
| Shares issued for offering costs |  |  |  |  | 25084 | 3 | 10783 | (10786) |  |  |
| Shares issued for option exercise |  |  |  |  | 250000 | 25 | 4875 |  |  | 4900 |
| Other changes |  |  |  |  |  |  |  |  | 954 | 954 |
| Net loss |  |  |  |  |  |  |  |  | (50208) | (50208) |
| Balance December 31, 2024 | 66666 | $7 | 41667 | $4 | 64713902 | $6331 | $3255117 | $- | $(1549152) | $1712307 |
| Net income |  |  |  |  |  |  |  |  | 94009 | 94009 |
| Balance June 30, 2025 | 66666 | $7 | 41667 | $4 | 64713902 | $6331 | $3255117 | $— | $(1455143) | $1806316 |

---

The accompanying notes are an integral part of these financial statements

**TriplePulse, Inc.**

**dba TruBrain**

Statements of Cash Flows

For the six months ended June 30,

(unaudited)

---

| | | |
|:---|:---|:---|
|  | 2025 | 2024 |
| **Cash flows from operating activities:** |  |  |
| Net Income | $94009 | $75948 |
| Changes in operating assets and liabilities: |  |  |
| Inventory | (67988) | 179515 |
| Other current assets |  |  |
| Change in right of use asset | 19910 | 4794 |
| Change in lease liability | (21120) | (4174) |
| Accounts payable and accrued expenses | (156133) | (160585) |
| Deferred revenue | (3290) | 1 |
| Accrued interest | 633 | 3656 |
| **Net cash provided by operating activities** | (133979) | 99155 |
| **Cash flows from financing activities:** |  |  |
| Proceeds from issuance of common stock |  | 4900 |
| Payments for notes payable |  | (5988) |
| **Net cash provided by (used in) financing activities** |  | (1088) |
| **Cash and cash equivalents and restricted cash:** |  |  |
| **Net change during the period** | (133979) | 98067 |
| **Balance, beginning of period** | 1524584 | 1318763 |
| **Cash and cash equivalents, ending** | $1390605 | $1416830 |
| **Supplemental cash flow information:** |  |  |
| Interest Paid | $2994 | $169 |
| Income taxes paid | $- | $- |

---

The accompanying notes are an integral part of these financial statements

**TriplePulse, Inc.<br> dba TruBrain**

Notes to the Financial Statements

**NOTE 1 – NATURE OF BUSINESS**

TriplePulse, Inc. dba TruBrain (the "Company") was incorporated on November 14, 2012 under the laws of the State of Delaware and is headquartered in Santa Monica, CA. The Company develops and produces special formulated brands of food and beverage to enhance brain function. The Company has marketed their products to consumers through an online platform.

**NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES**

<u>Basis of Presentation</u>

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). The Company's year-end is December 31.

<u>Use of Estimates</u>

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

<u>Fair Value of Financial Instruments</u>

Financial Accounting Standards Board ("FASB") guidance specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The three levels of the fair value hierarchy are as follows:

*Level 1* - Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded instruments and listed equities.

*Level 2* - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly (e.g., quoted prices of similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active).

*Level 3* - Unobservable inputs for the asset or liability. Financial instruments are considered Level 3 when their fair values are determined using pricing models, discounted cash flows or similar techniques and at least one significant model assumption or input is unobservable.

The carrying amounts reported in the balance sheets approximate their fair value.

<u>Cash and Cash Equivalents</u>

The Company considers all highly liquid investments with an original maturity of 90 days or less to be cash equivalents. The Company holds cash in accounts with major financial institutions and brokerage firms. Balances in these accounts may exceed FDIC-insured limits of $250,000. The Company participates in an FDIC-insured sweep program through brokerage accounts. Cash balances are automatically transferred into interest-bearing accounts at multiple FDIC-member banks, ensuring that cash balances remain within FDIC and SIPC insurance limits. At June 30, 2025 and December 31, 2024 the company had cash balances of $1,390,605 and $1,524,584, which are in $277,069 and $421,915 over the insured limits, respectively. No losses have been recognized as a result of these excess amounts.

<u>Inventory</u>

Inventory is stated at the lower of cost or market value and is accounted for using the first-in-first-out method ("FIFO"). The Company analyzes inventory per any potential obsolescence, and records impairment and obsolescence reserve against inventory as deemed necessary and based on historical experience. As of June 30, 2025 and December 31, 2024 the Company had an impairment allowance of $17,922 and $17,922, respectively.

<u>Revenue Recognition</u>

During the year ended December 31, 2019, the Company adopted Accounting Standards Update (ASU) 2014-01, "Revenue from Contracts with Customers" which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers (Accounting Standards Codification "ASC" Topic 606) and supersedes most current revenue recognition guidance (ASC Topic 605). ASC Topic 606 outlines the following five-step process for revenue recognition:

· Identification of the contract
with a customer;

· Identification of the performance
obligations in the contract;

· Determination of the transaction
price;

· Allocation of the transaction
price to the performance obligations in the contract; and

· Recognition of revenue when, or
as, the Company satisfies the performance obligations.

The Company recognizes revenue when the performance obligations have been met, which is typically at the time of shipment. Return reserves are estimated based on historical experiences.

Deferred revenue consists of cash received from customers for purchase commitments that are monthly, quarterly, bi-annual and annual of the product sold on the Company's website. Revenue from these purchases is deferred and recognized as the performance obligation is met. As of June 30, 2025, and December 31, 2024, the Company had $17,030 and $20,320 in deferred revenue, respectively.

<u>Advertising costs</u>

The Company's advertising costs are expensed as incurred. During the six months ended June 30, 2025 and 2024, the Company recognized $226,914 and $176,741 in advertising, respectively.

<u>Stock-Based Compensation</u>

During the year ended December 31, 2019, the Company adopted ASU 2018-07, Compensation – Stock Compensation (Topic 718) that accounts for non-employee awards in the same manner as employee awards. Under the fair value recognition provisions of ASC 718, stock-based compensation cost is measured at the grant date based on the fair value of the award and is recognized as expense ratably over the requisite service period, which is generally the option vesting period.

<u>Stock Split</u>

On September 11, 2019, the Board of Directors approved a 50:1 common stock split. Share and per share amounts for all periods presented in the accompanying financial statements and notes herein have been adjusted retroactively, where applicable, to reflect the stock split.

<u>Convertible Debt</u>

The Company evaluated the convertible debt under the guidelines established by ASC 470-20, Debt with Conversion and Other Options. ASC 470-20 governs the calculation of an embedded beneficial conversion and/or debt issued with warrants, which is treated as a discount to the instruments where derivative accounting does not apply.

<u>Offering Costs</u>

The Company accounts for offering costs in accordance with ASC 340, Other Assets and Deferred Costs. Prior to the completion of an offering, offering costs are capitalized as deferred offering costs on the balance sheet. The deferred offering costs are netted against the proceeds of the offering in stockholders' deficit. If the offering is unsuccessful, such costs are expensed.

<u>Preferred Stock</u>

ASC 480, Distinguishing Liabilities from Equity, includes standards for how an issuer of equity classifies and measures on its balance sheet certain financial instruments with characteristics of both liabilities and equity. Management is required to determine the presentation for the preferred stock as a result of the redemption and conversion provisions in the agreement. Specifically, management is required to determine whether the embedded conversion feature in the preferred stock is clearly and closely related to the host instrument, and whether the bifurcation of the conversion feature is required, and the conversion feature should be accounted for as a derivative instrument. If the host instrument and conversion feature are determined to be clearly and closely related (both more akin to equity), derivative liability accounting under ASC 815, Derivatives and Hedging, is not required. Management determined that the host contract of the preferred stock is more akin to equity, and accordingly, liability accounting is not required by the Company. The Company has presented preferred stock within stockholders' equity in the accompanying balance sheet.

<u>Earnings per Common Share</u>

Basic earnings per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income (loss) by the weighted average number of common shares and dilutive potential common shares outstanding during the period. Diluted earnings per common shares includes the dilutive effect of the additional potential common shares issuable under convertible debt, stock options, warrants, and preferred shares as fully converted.

Earnings and dividends per share are restated for all stock splits through the date of issuance of the financial statements.

<u>Research and Development Costs</u>

Research and development costs are expensed as incurred. We incur research and development costs to improve and expand our product offerings, introduce new technologies to customers, and support our sales channels to generate consumer interest and engagement. These costs typically include components such as formulation, personnel related expenses, consulting expenses, prototype materials, market research, analytical laboratory testing, and user testing. For the six months ended June 30, 2025 and 2024, the Company recognized $45,216 and $14,541 in research and development costs, respectively, which have been in included in general and administrative costs in the accompanying statements of operations.

<u>Shipping and Handling Costs</u>

Shipping and handling costs are included in cost of goods sold and expensed as incurred. For the six months ended June 30, 2025 and 2024, the Company incurred $122,894 and $96,763 in shipping and handling costs, respectively.

<u>Recent Accounting Pronouncements</u>

In December 2023, the FASB issued ASU 2023-09 "Income Taxes (Topic 740): improvements to Income Tax Disclosures" to expand the disclosure requirements for income taxes, specifically related to the rate reconciliation and income taxes paid. ASU 2023-09 is effective for annual periods beginning January 1, 2025, with early adoption permitted. We are currently evaluating the potential effect that the updated standard will have on the financial statement disclosures.

**NOTE 3 – GOING CONCERN**

The Company has incurred cumulative losses of approximately $1.4 million as of June 30, 2025, and has historically experienced negative operating cash flows. However, in recent periods, the Company has achieved profitability and generated positive operating cash flows. Management has evaluated the Company's ability to continue as a going concern and believes that the recent improvements in operating performance and cash flow generation provide sufficient liquidity to support ongoing operations for the foreseeable future.

**NOTE 4 – NOTES PAYABLE**

On July 8, 2020, the Company entered into a loan with Coastal Community Bank, guaranteed by the U.S. Small Business Administration (SBA), in the amount of $150,000, with monthly payments beginning July 8, 2021, in the amount of $751 per month for a term of thirty (30) years, with an interest rate of 3.75% per annum.

On July 30, 2021, the U.S. Small Business Administration amended the loan and advanced an additional $45,000, increasing the principal balance to $195,000. Monthly payments beginning January 2023 are $998 per month for a term of thirty (30) years, with an interest rate of 3.75% per annum.

At June 30, 2025 and December 31, 2024 the outstanding balance on this note was $195,000 and $195,000, respectively.

**NOTE 5 – COMMITMENTS AND CONTINGENCIES**

Except as may be set forth below, we are not a party to any legal proceedings, and we are not aware of any claims or actions pending or threatened against us. In the future, we might from time to time become involved in litigation relating to claims arising from our ordinary course of business, the resolution of which we do not anticipate would have a material adverse impact on our financial position, results of operations or cash flows.

*Concentration*

The Company uses one primary contract manufacturer and fulfillment center for its top revenue producing drink products. This represents concentrated risks for the main source of revenue for the Company. An adverse impact to one or both of these facilities and/or vendors would cause a material impact on the Company's operations.

*Lease*

The Company's prior lease expired during the six months ended June 30, 2025. On May 1, 2025, the Company entered into a month-to-month lease with a term of one year commencing May 1, 2025. Monthly base rent is $5,350. The Company elected the short-term lease exception and, accordingly, did not recognize a right-of-use asset or lease liability for this lease with a term of less than 12 months.

Rent expense for the six months ended June 30, 2025 and 2024 was $41,574 and $32,074, respectively.

**NOTE 6 – CONVERTIBLE DEBT**

The Company issued convertible debt for cash proceeds of $1,455,000 in 2014 and 2015, of which $675,000 was with related parties. These securities are convertible into common stock of the Company, matured 24 months from the date of issuance, and contain a 5% stated rate of interest prior to maturity with 10% default interest after maturity. The convertible debt may be converted upon the following:

1. Automatic conversion - Upon a qualified financing, which is set to occur upon a bona fide sale of equity in minimum amount ranging from $500,000 to $1,500,000, the outstanding principal and interest convert into that number of shares of the stock issued in the Qualified Financing (the "Qualified Financing Stock") and shares of Common Stock of the Company determined by dividing the Outstanding Amount by a conversion price equal to the lesser of (i) the price per share of the Qualified Financing Stock sold by the Company in the Qualified Financing, discounted by 20%, and (ii) the price determined by dividing a pre-money valuation of $4,000,000.00 by the number of outstanding shares of the Common Stock on a fully-diluted and as-converted basis immediately prior to the closing of the Qualified Financing (not including the Excluded Shares). Of those shares, the number of Qualified Financing Stock will equal (x) the Outstanding Amount, divided by (y) the price per share paid by the other investors purchasing the Qualified Financing Stock in the Qualified Financing. Any remaining shares will be Common Stock.

The Qualified Financing Stock delivered to Holder pursuant to such conversion shall have the same rights, preferences, privileges as the Qualified Financing Stock delivered to other investors in the Qualified Financing, and Holder shall enjoy the same contractual rights as other investors in the Qualified Financing.

2. Optional conversion - Upon no qualified financing or change of control transaction and outside maturity date, the holder may provide written notice to be delivered to the Company to convert the security into the number of shares of common stock by dividing the outstanding amount by a pre-money valuation of $4,000,000 by the number of outstanding shares of common stock on a fully-diluted and as converted basis.

3. Change of Control - Upon a change in control transaction, the Company shall redeem the Notes at the election of the purchaser for an amount equal to a) 100-200% of the outstanding amount (depending on the terms of the individual note), or b) the consideration which the holder would have received in the change in control transaction (to be paid in the same form of consideration) had the holder converted outstanding principal and interest into shares of common stock of the Company at a conversion price per share determined by dividing a pre-money valuation of $4,000,000 by the number of outstanding shares of common stock on a fully-dilutive basis.

In 2019, the qualified financing thresholds of $500,000 and $750,000 were triggered, and therefore, convertible notes including interest thereon totaling $844,896, converted into 2,293,605 shares of common stock.

On August 2, 2021, the company converted $175,000 plus accrued interest of $89,154 into 2,786,738 shares of its common stock which were un-issued as of December 31, 2021 and accounted for in shares to be issued. These shares were issued in the year ended December 31, 2022.

On June 15, 2023, the company converted $675,000 plus accrued interest of $473,698 into 12,121,688 shares of its common stock, which were issued as of December 31, 2023.

For the six months ended June 30, 2024 and 2023, the Company recognized interest expense on the convertible notes of $0 and $33,750, respectively.

As of June 30, 2024 and December 31, 2023, the Company had zero outstanding convertible promissory notes and zero outstanding balance owed to related parties because each of the related party convertible notes were converted on June 15, 2023.

**NOTE 7 – STOCKHOLDERS' DEFICIT**

<u>Common Stock</u>

The Company is authorized to issue 100,000,000 shares of common stock, $0.0001 par value per share.

During the six-months ended June 30, 2024, the Company issued 25,084 shares of Common stock to a related party as a compensation for the services rendered in the Regulation A+ fundraising. During the six-months ended June 30, 2024, the Company received $4,900 and issued 250,000 to a former Director for stock option exercise.

<u>Preferred Stock</u>

The Company is authorized to issue 66,667 shares of Series A Preferred Stock, $0.0001 par value and 41,667 shares of Series B Preferred stock, $0.0001 par value; collectively referred to as the "Preferred Stock".

**Conversion rights** – The holders of Preferred Stock have the following conversion rights:

Each share of Preferred Stock is convertible, at any time, at the option of the holder thereof, into such number of fully paid and non-assessable shares of Common Stock as is determined by dividing the Initial Issue Price of the Preferred Stock (as appropriately adjusted for stock splits, stock dividends, recapitalizations and the like) by the then applicable Conversion Price for a share of Preferred Stock. The Initial Issue Price per share of Series Seed Preferred Stock is $0.30 per share, and of Series Seed-B Preferred Stock $0.60 per share. Due to the stock-split noted above, each share of preferred stock is convertible into 50 shares of common stock.

Each share of Preferred Stock shall automatically be converted into Common Stock immediately upon the earlier of (a) the closing of a firm commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, or (ii) the date, time, or occurrence of an event specified by written consent or agreement of the holders of at least a majority of the then outstanding shares of Preferred Stock, voting together as a single class.

**Additional Financing Rights:** – In the event the Company issues securities in its subsequent equity financings which have (a) rights, preferences or privileges that are more favorable than the terms of Investor, such as price based anti-dilution protection, or (b) provides all such future investors other contractual terms such as preemptive rights or registration rights, the Company shall provide substantially equivalent rights to Investor.

**Liquidation rights** – Upon a liquidation, dissolution or winding up of the corporation, or deemed liquidation event, the holders of our Series Seed Preferred Stock and Series Seed-B Preferred Stock, are entitled to receive the greater of the a) Initial Issue price plus any declared and unpaid dividends, or b) such amount per share as would have been payable had preferred stock been converted into common stock immediately before such event, in distributions, before any funds are distributed to the holders of common stock. As of the date hereof, upon a Liquidation Event, the holders of outstanding preferred stock would be entitled to receive the first $45,000 in distributions as stated in agreements, with the remaining amounts being split pro rata amongst the holders of common stock.

**Voting rights** – The holders of preferred stock shall have the right to one vote for each share of common stock into which such preferred stock could then be converted with the same voting rights and powers of common shareholders, except with respect to the election of directors. As long as there are any shares of preferred stock outstanding, we may not, do any of the following without the vote of the holders of a majority of the outstanding shares of preferred stock, voting together as a single class: (1) alter or change the rights, powers or privileges of the preferred stock as set forth in our Certificate of Incorporation, in any way that adversely affects the preferred stock, (2) increase or decrease the authorized number of shares of preferred stock (or any series thereof), (3) authorize or create any new class or series of capital stock having rights, powers or privileges that are senior to any series of preferred stock, (4) redeem or repurchase any shares of common stock or preferred stock (other than pursuant to employee or consulting agreements giving us the right to repurchase such share at the original cost thereof upon termination of services, or (5) declare or pay any dividend or otherwise make a distribution to the holders of preferred stock or common stock. Therefore, the holders of our preferred stock, may prevent us from taking certain corporate actions, that our board of directors may be in the best interests of the holders of our common stock. See "Securities Being Offered – Certificate of Incorporation – Voting Rights."

**Dividend Rights** – All dividends shall be declared pro rata on the shares of Common Stock and Preferred Stock, on a pari passu basis according to the number of shares of Common Stock held by such holders, or, in the case of Preferred Stock, the number of shares of Common Stock, into which such shares of Preferred Stock are convertible as of the record date for the payment of such dividends.

**Other Rights of Holders of Preferred Stock** – We are party to an Investors' Rights Agreement with StartEngine Fund I, L.P., the holder of our Series Seed Preferred Stock, pursuant to which, in addition to holding certain information rights, StartEngine has a right of first refusal to purchase a specified portion of any new securities we may sell in the future.

<u>Stock Options</u>

In 2014, the Board of Directors adopted the TriplePulse, Inc. 2014 Incentive Plan (the "2014 Plan"). The 2014 Plan provides for the grant of equity awards to purchase shares of common stock. Up to 14,250,000 shares of common stock may be issued pursuant to awards granted under the 2014 Plan. The 2014 Plan is administered by the Board of Directors, and expires ten years after adoption, unless terminated earlier by the Board.

The Company has 8,158,197 shares issued and 6,091,803 shares remaining for issuance under the 2014 stock plan.

Total stock option activity for the six months ended June 30, 2025 was as follows:

---

| | | | |
|:---|:---|:---|:---|
|  |<br>Stock<br>Options | Weighted<br>Average<br>Exercise<br>Price | Weighted<br>Average<br>Contractual<br>Life (years) |
| Outstanding at December 31, 2023 | 250000 | 0.02 | 2.6 |
| Granted |  |  |  |
| Exercised | 250000 | 0.02 |  |
| Forfeited | - | - | - |
| Outstanding at December 31, 2024 | - | - | - |
| Granted |  |  |  |
| Exercised |  |  |  |
| Forfeited | - |  | - |
| Outstanding at June 30, 2025 | - | - | - |

---

<u>Warrants</u>

The outstanding warrants are fully vested.

---

| | | | |
|:---|:---|:---|:---|
|  |<br><br>Warrants | Weighted<br>Average<br>Exercise<br>Price | Weighted<br>Average<br>Contractual<br>Life (years) |
| Outstanding at December 31, 2023 | 211350 | $0.04 | 1.13 |
| &nbsp;&nbsp;&nbsp;Granted |  |  |  |
| &nbsp;&nbsp;&nbsp;Expired | 98450 | 0.03 |  |
| &nbsp;&nbsp;&nbsp;Forfeited | - |  | - |
| Outstanding at December 31, 2024 | 112900 | $0.04 | 0.90 |
| &nbsp;&nbsp;&nbsp;Granted |  |  |  |
| &nbsp;&nbsp;&nbsp;Expired |  |  |  |
| &nbsp;&nbsp;&nbsp;Forfeited | - | - | - |
| Outstanding at June 30, 2025 | 112900 | $0.04 | 0.40 |

---

**NOTE 8 – SUBSEQUENT EVENTS**

In accordance with ASC 855, the Company has analyzed its operations subsequent to June 30, 2025 through the date these financial statements were issued and has determined that it does not have any other material subsequent events to disclose in these financial statements.

**Item 4. Exhibits**

The documents listed in the Exhibit Index of this report are incorporated by reference or are filed with this report, in each case as indicated below.

---

| | |
|:---|:---|
| [2.1](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex2-1.htm) | [Certificate of Incorporation\*](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex2-1.htm) |
| [2.2](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex2-2.htm) | [Amended and Restated Certificate of Incorporation\*](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex2-2.htm) |
| [2.3](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex2-3.htm) | [Second Amended and Restated Certificate of Incorporation\*](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex2-3.htm) |
| [2.4](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex2-4.htm) | [Amendment to Second Amended and Restated Certificate of Incorporation\*](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex2-4.htm) |
| [2.5](tp009_ex2-5.htm) | [Bylaws](tp009_ex2-5.htm) |
| [3.1](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex3-1.htm) | [Investors' Rights Agreement between TriplePulse, Inc., Christopher Thompson and Brightstone Venture Capital Fund, L.P.\*](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex3-1.htm) |
| [4.1](https://www.sec.gov/Archives/edgar/data/1603707/000110465922070484/tm2218269d1_ex4-1.htm) | [Form of Subscription Agreement\*\*](https://www.sec.gov/Archives/edgar/data/1603707/000110465922070484/tm2218269d1_ex4-1.htm) |
| [6.1](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex6-8.htm) | [EIDL Loan from the United States Small Business Association\*](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex6-8.htm) |
| [6.2](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex6-9.htm) | [Warrant W-1 for StartEngine Fund I, L.P.\*](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex6-9.htm) |
| [6.3](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex6-10.htm) | [Warrant W-2 for StartEngine Fund I, L.P.\*](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex6-10.htm) |
| [6.4](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex6-11.htm) | [Warrant W-3 for StartEngine Fund I, L.P.\*](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex6-11.htm) |
| [6.5](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex6-12.htm) | [Warrant W-4 for StartEngine Fund I, L.P.\*](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex6-12.htm) |
| [6.6](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex6-13.htm) | [Warrant W-5 for StartEngine Fund I, L.P.\*](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex6-13.htm) |
| [6.7](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex6-14.htm) | [Warrant W-6 for StartEngine Fund I, L.P.\*](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex6-14.htm) |
| [6.8](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex6-15.htm) | [TriplePulse, Inc. Stock Plan\*](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex6-15.htm) |
| [6.9](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex6-19.htm) | [Patent License Agreement\*](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/tm2031356d1_ex6-19.htm) |
| [8.1](https://www.sec.gov/Archives/edgar/data/1603707/000110465922070484/tm2218269d1_ex8-1.htm) | [Escrow Services Agreement\*\*\*](https://www.sec.gov/Archives/edgar/data/1603707/000110465922070484/tm2218269d1_ex8-1.htm) |

---

**(\*) Filed as an exhibit to the TriplePulse, Inc. Regulation A Offering Statement on Form 1-A (Commission File No. 024-11329) and incorporated herein by reference. Available at, [https://www.sec.gov/Archives/edgar/data/0001603707/000110465920110040/0001104659-20-110040-index.htm](https://www.sec.gov/Archives/edgar/data/1603707/000110465920110040/0001104659-20-110040-index.htm)**

**(\*\*) Filed as an exhibit to the TriplePulse, Inc. Regulation A Offering Statement on Form 1-A POS (Commission File No. 024-11329) and incorporated herein by reference. Available at,** [**https://www.sec.gov/Archives/edgar/data/1603707/000110465922070484/tm2218269d1_ex4-1.htm**](https://www.sec.gov/Archives/edgar/data/1603707/000110465922070484/tm2218269d1_ex4-1.htm)

**(\*\*\*) Filed as an exhibit to the TriplePulse, Inc. Regulation A Offering Statement on Form 1-A POS (Commission File No. 024-11329) and incorporated herein by reference. Available at, [https://www.sec.gov/Archives/edgar/data/1603707/000110465922070484/tm2218269d1_ex8-1.htm](https://www.sec.gov/Archives/edgar/data/1603707/000110465922070484/tm2218269d1_ex8-1.htm)**

**SIGNATURES**

**Pursuant to the requirements of Regulation A, the issuer has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Los Angeles, State of California, on September 25, 2025.**

---

| |
|:---|
| **TriplePulse, Inc.** |
| **/s/ Christopher Thompson** |
| **By: Christopher Thompson, Chief Executive Officer** |
| **Date: September 25, 2025** |

---

**Pursuant to the requirements of Regulation A, this report has been signed below by the following persons on behalf of the issuer and in the capacities and on the date indicated.**

---

| | |
|:---|:---|
| **By:** | **/s/ Christopher Thompson** |
|  | **Christopher Thompson, Chief Executive**<br> **Officer, Director**  |
| **Date:** | **September 25, 2025** |

---

## Ex1Sa-2B

**Exhibit 2.5**

BYLAWS OF

TRIPLEPULSE, INC.

(A Delaware Corporation)

ARTICLE I

OFFICES

SECTION 1. Registered Office. The registered office of the Corporation within the State of Delaware shall be in the City of Dover, County of Kent. The name of the registered agent of the Corporation at such location is A Registered Agent, Inc., and may, from time-to-time, be changed as the Corporation may require.

SECTION 2. Other Offices. The Corporation may also have an office or offices other than said registered office at such place or places, either within or without the State of Delaware, the business of the Corporation may require.

ARTICLE II

MEETINGS OF STOCKHOLDERS

SECTION 1. Place of Meetings. All meetings of stockholders shall be held at any place, either within or without the State of Delaware, as shall be designated from time to time by the (a) President, (b) CEO, or (c) the entire Board of Directors as a whole. In the event that a virtual meeting is preferable, in lieu of a physical meeting, these meetings may also be attended, participated, and voted in by telephone conference calls or other electronic means.

SECTION 2. Annual Meeting. The annual meeting of the stockholders shall be held at such time as shall be designated from time to time by the (a) President, (b) CEO, or (c) the entire Board of Directors as a whole. The annual meeting requires the approval of the President.

SECTION 3. Special Meetings. Special meetings of stockholders, unless otherwise prescribed by statute, may only be called, at any time, by the President, the CEO, the Chairman of the Board, or by stockholders holding shares in the aggregate entitled to cast not less than a majority percent of votes at the meeting.

SECTION 4. Notice of Meetings. Except as otherwise expressly required by statute, written notice of each annual and special meeting of stockholders stating the date, place and hour of the meeting, and, in the case of a special meeting, the purpose or purposes for which the meeting is called, shall be given to each stockholder of record entitled to vote at such meeting not less than (7) days before the date of the meeting. Notice shall be given personally or by mail, or by electronic mail. Notice by mail shall be deemed given at the time when the same shall be deposited in the United States mail, postage prepaid. Notice of any meeting shall not be required to be given to any person who attends such meeting, except when such person attends the meeting in person or by proxy for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened, or who, either before or after the meeting, shall submit a signed written waiver of notice, in person or by proxy. Neither the business to be transacted at, nor the purpose of, an annual or special meeting of stockholders need be specified in any written waiver of notice.

SECTION 5. Quorum, Adjournments. The holders of a majority of the voting power of the issued and outstanding stock of the Corporation entitled to vote thereat, present in person or represented by proxy, shall constitute a quorum for the transaction of business at all meetings of stockholders, except as otherwise provided by statute or by the Certificate of Incorporation. If, however, such quorum shall not be present or represented by proxy at any meeting of stockholders, then either (a) the President, (b) the CEO, or (c) the stockholders holding shares in the aggregate entitled to cast not less than a majority percent of votes at the meeting, shall have the power to adjourn the meeting to another place, date, or time.

SECTION 6. Organization. At each meeting of stockholders, the President or CEO shall act as chairman of the meetings. The Secretary or, in his absence or inability to act, the person whom the chairman of the meeting shall appoint secretary of the meeting shall act as secretary of the meeting and keep the minutes thereof.

SECTION 7. Order of Business. The order of business at all meetings of the stockholders shall be as determined by the President or the chairman of the meeting.

SECTION 8. Voting. Except as otherwise provided by statute or the Certificate of Incorporation, each stockholder of the Corporation entitled to vote at any such meetings, shall be entitled to one vote for each share of capital stock of the Corporation standing in his name on the record of stockholders of the Corporation:

(a) on the date fixed pursuant to the provisions of Section 7 of Article V of these bylaws as the record date
for the determination of the stockholders who shall be entitled to notice of and to vote at such meeting; or

(b) if no such record date shall have been so fixed, then at the close of business on the day next preceding
the day on which notice thereof shall be given, or, if notice is waived, at the close of business on the date next preceding the day on
which the meeting is held.

Each stockholder entitled to vote at any meeting of stockholders may authorize another person or persons to act for him by a proxy signed by such stockholder or his attorney in fact, but no proxy shall be voted after three years from its date, unless the proxy provides for a longer period. Any such proxy shall be delivered to the secretary of the meeting at or prior to the time designated in order of business for so delivering such proxies. When a quorum is present at any meeting, the vote of the holders of a majority of the voting power of the issued and outstanding stock of the Corporation entitled to vote thereon, present in person or represented by proxy, shall decide any question brought before such meeting, unless the question is one upon which by express provision of statute or of the Certificate of Incorporation or of these bylaws, a different vote is required, in which case such express provision shall govern and control the decision of such question. Unless required by statute, or determined by the President or the chairman of the meeting to be advisable, the vote on any question need not be by ballot. On a vote by ballot, each ballot shall be signed by the stockholder voting, or by his proxy, if there by such proxy, and shall state the number of shares voted.

SECTION 9. Action Without a Meeting. Unless otherwise provided in the Certificate of Incorporation, any action required to be taken at any annual or special meeting of stockholders of the corporation, or any action which may be taken at any annual or special meeting of such stockholders, may be taken without a meeting, without prior notice and without a vote, if a consent in writing, setting forth the action so taken, shall be signed by the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted. Prompt notice of the taking of the corporate action without a meeting by less than unanimous written consent shall be given to those stockholders who have not consented in writing.

SECTION 10. Telephonic Meeting. Unless restricted by the Certificate of Incorporation, any one or more stockholder may participate in a meeting of the stockholders by means of a conference telephone or similar communications equipment by means of which all persons participating in the meeting can hear each other. Participation by such means shall constitute presence in person at a meeting.

ARTICLE III

BOARD OF DIRECTORS

SECTION 1. General Powers. The business and affairs of the Corporation shall be managed by or under the direction of the President and CEO. The executive officers may exercise all such authority and powers of the Corporation, subject to the Company's specific objectives or requirements in accordance with applicable laws and the Certificate of Incorporation.

SECTION 2. Number, Election and Term of Office. The number of directors constituting the Board of Directors may be fixed, from time to time, by the appointment of the President. Any decrease in the number of directors shall be effective at the time of the next succeeding annual meeting of stockholders unless there shall be vacancies in the Board of Directors, in which case such decrease may become effective at any time prior to the next succeeding annual meeting to the extent of the number of such vacancies. Directors need not be stockholders. Each director shall hold office until his successor has been qualified, or until his death, or until he shall have resigned, or have been removed.

SECTION 3. Place of Meetings. Meetings of the Board of Directors shall be held at such place or places, within or without the State of Delaware, as the Board of Directors may from time to time determine or as shall be specified in the notice of any such meeting.

SECTION 4. Annual Meeting. The Board of Directors shall meet for the purpose of organization and normal transaction of business, as soon as practicable after each annual meeting of stockholders, on the same day and at the same place where such annual meeting shall be held. Notice of such meeting need not be given. In the event such annual meeting is not so held, the annual meeting of the Board of Directors may be held at such other time or place (within or without the State of Delaware) as shall be specified in a notice thereof given as hereinafter provided in Section 7 of this Article III.

SECTION 5. Regular Meetings. Regular meetings of the Board of Directors shall be held at such time and place set by the President or CEO. If any day fixed for the regular meeting shall be a legal holiday at the place where the meeting is to be held, then the meeting which would otherwise be held on that day shall be held at the same hour on the next succeeding business day. Notice of regular meetings of the Board of Directors need not be given except as otherwise required by statute or these bylaws.

SECTION 6. Special Meetings. Special meetings of the Board of Directors may only be called, at any time, by the President, the CEO, the Chairman of the Board, or by stockholders holding shares in the aggregate entitled to cast not less than a majority percent of votes at the meeting.

SECTION 7. Notice of Meetings. Notice of each special meeting of the Board of Directors (and of each regular meeting for which notice shall be required) shall be given by the Secretary as hereinafter provided in this Section 7, in which notice shall be stated the time and place of the meeting. Except as otherwise required by these bylaws, such notice need not state the purposes of such meeting. Notice of each such meeting shall be mailed, postage prepaid, to each director, addressed to him at his residence or usual place of business, by first class mail, at least two days before the day on which such meeting is to be held, or shall be sent addressed to him at such place by telegraph, cable, telex, telecopier or other similar means, or be delivered to him personally or be given to him by telephone or other similar means, at least twenty four hours before the time at which such meeting is to be held. Notice of any such meeting need not be given to any director who shall, either before or after the meeting, submit a signed waiver of notice or who shall attend such meeting, except when he shall attend for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened.

SECTION 8. Quorum and Manner of Acting. A quorum for the transaction of business at any meeting of the Board of Directors shall require the presence of all members of the Board of Directors. However, the President shall have the authority to hold a meeting at their discretion, even if not all members of the Board of Directors are present. No business shall be transacted at any meeting unless every director is present, either in person or via permissible electronic communication as detailed in these bylaws. In the event that not all directors are present at a scheduled meeting, thereby lacking a quorum, those directors present may adjourn the meeting to another time and place. Notice of the rescheduled meeting shall be given to all directors. At the rescheduled meeting where all directors are present, any business may be conducted that could have been transacted at the originally scheduled meeting.

SECTION 9. Organization. At each meeting of the Board of Directors, the Chairman of the Board, if one shall have been elected, or, in the absence of the Chairman of the Board or if one shall not have been elected, the President shall act as chairman of the meeting and preside thereat. The Secretary or, in his absence, any person appointed by the chairman shall act as secretary of the meeting and keep the minutes thereof.

SECTION 10. Resignations. Any director of the Corporation may resign at any time by giving written notice of his resignation to the Corporation. Any such resignation shall take effect at the time specified therein or, if the time when it shall become effective shall not be specified therein, immediately upon its receipt. Unless otherwise specified therein, the acceptance of such resignation shall not be necessary to make it effective.

SECTION 11. Vacancies. Any vacancy in the Board of Directors, whether arising from death, resignation, removal, an increase in the number of directors or any other cause, may be filled only by the appointment of the President.

SECTION 12. Compensation. The Board of Directors shall not be compensated in cash or cash equivalents for their services as members of the Board of Directors. This shall not preclude any director from serving the Corporation in any other capacity and receiving compensation therefor.

SECTION 13. Committees. The formation and designation of any and all committees, including but not limited to an executive committee and a stock plan committee, shall be the exclusive prerogative of the President or the Chief Executive Officer (CEO) of TriplePulse, Inc. Each committee shall consist of one or more of the officers or directors as appointed solely by the President or CEO. The specific functions, powers, and duties of each committee shall be as determined from time to time by the President or CEO. All such committees shall operate under the direction of, and report directly to, the President or CEO. This section precludes the Board of Directors from forming or designating any committees independently.

SECTION 14. Action by Written Consent Without a Meeting. Unless restricted by the Certificate of Incorporation, any action required or permitted to be taken by the Board of Directors or any committee thereof may be taken without a meeting if all members of the Board of Directors or such committee, as the case may be, consent thereto in writing, and the writing or writings are filed with the minutes of the proceedings of the Board of Directors or such committee, as the case may be.

SECTION 15. Telephonic Meeting. Unless restricted by the Certificate of Incorporation, any one or more members of the Board of Directors or any committee thereof may participate in a meeting of the Board of Directors or such committee by means of a conference telephone or similar communications equipment by means of which all persons participating in the meeting can hear each other. Participation by such means shall constitute presence in person at a meeting.

ARTICLE IV

STOCK CERTIFICATES AND THEIR TRANSFER

SECTION 1. Stock Certificates. The shares of the Corporation shall be represented by certificates, whether physical or digital representations, and every holder of stock in the Corporation shall be entitled to have a certificate in the name of the Corporation. If the Corporation shall be authorized to issue more than one class of stock or more than one series of any class, the designations, preferences and relative, participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restriction of such preferences and/or rights shall be set forth in full or summarized on the face or back of the certificate which the Corporation shall issue to represent such class or series of stock, provided that, except as otherwise provided in Section 202 of the General Corporation Law of the State of Delaware, in lieu of the foregoing requirements, there may be set forth on the face or back of the certificate which the Corporation shall issue to represent such class or series of stock, a statement that the Corporation will furnish without charge to each stockholder who so requests the designations, preferences and relative, participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences and/or rights.

SECTION 2. Facsimile Signatures. Any or all of the signatures on a certificate may be a facsimile. In case any officer, transfer agent or registrar who has signed or whose facsimile signature has been placed upon a certificate shall have ceased to be such officer, transfer agent or registrar before such certificate is issued, it may be issued by the Corporation with the same effect as if he were such officer, transfer agent or registrar at the date of issue.

SECTION 3. Lost Certificates. The Board of Directors may direct a new certificate or certificates to be issued in place of any certificate or certificates theretofore issued by the Corporation alleged to have been lost, stolen, or destroyed. When authorizing such issue of a new certificate or certificates, the Board of Directors may, in its discretion and as a condition precedent to the issuance thereof, require the owner of such lost, stolen, or destroyed certificate or certificates, or his legal representative, to give the Corporation a bond in such sum as it may direct sufficient to indemnify it against any claim that may be made against the Corporation on account of the alleged loss, theft or destruction of any such certificate or the issuance of such new certificate.

SECTION 4. Transfers of Stock. Upon surrender to the Corporation or the transfer agent of the Corporation of a certificate for shares duly endorsed or accompanied by proper evidence of succession, assignment or authority to transfer, it shall be the duty of the Corporation to issue a new certificate to the person entitled thereto, cancel the old certificate and record the transaction upon its records; provided, however, that the Corporation shall be entitled to recognize and enforce any lawful restriction on transfer. Whenever any transfer of stock shall be made for collateral security, and not absolutely, it shall be so expressed in the entry of transfer if, when the certificates are presented to the Corporation for transfer, both the transferor and the transferee request the corporation to do so.

SECTION 5. Transfer Agents and Registrars. The Board of Directors may appoint, or authorize any officer or officers to appoint, one or more transfer agents and one or more registrars.

SECTION 6. Fixing the Record Date. In order that the Corporation may determine the stockholders entitled to notice of or to vote at any meeting of stockholders or any adjournment thereof, or to express consent to corporate action in writing without a meeting, or entitled to receive payment of any dividend or other distribution or allotment of any rights, or entitled to exercise any right in respect of any change, conversion or exchange of stock or for the purpose of any other lawful action, the Board of Directors may fix, in advance, a record date, which shall not be more than sixty nor less than ten days before the date of such meeting, nor more than sixty days prior to any other action. A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting; provided, however, that the Board of Directors may fix a new record date for the adjourned meeting.

SECTION 7. Registered Stockholders. The Corporation shall be entitled to recognize the exclusive right of a person registered on its records as the owner of shares of stock to receive dividends and to vote as such owner, shall be entitled to hold liable for calls and assessments a person registered on its records as the owner of shares of stock, and shall not be bound to recognize any equitable or other claim to or interest in such share or shares of stock on the part of any other person, whether or not it shall have express or other notice thereof, except as otherwise provided by the laws of Delaware.

ARTICLE V

INDEMNIFICATION OF DIRECTORS AND OFFICERS

SECTION 1. General. The Corporation may, at its discretion, indemnify any person who was or is a party, or is threatened to be made a party, to any action, suit, or proceeding, whether civil, criminal, administrative, or investigative (other than an action by or in the right of the Corporation) by reason of the fact that they are or were a director, officer, employee, or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee, or agent of another corporation, partnership, joint venture, trust, or other enterprise, against expenses (including attorneys' fees), judgments, fines, and amounts paid in settlement actually and reasonably incurred by them in connection with such action, suit, or proceeding if they acted in good faith and in a manner they reasonably believed to be in or not opposed to the best interests of the Corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe their conduct was unlawful.

SECTION 2. Derivative Actions. The Corporation may, at its discretion, indemnify any person who was or is a party, or is threatened to be made a party, to any action or suit by or in the right of the Corporation to procure a judgment in its favor by reason of the fact that they are or were a director, officer, employee, or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee, or agent of another corporation, partnership, joint venture, trust, or other enterprise against expenses (including attorneys' fees) actually and reasonably incurred by them in connection with the defense or settlement of such action or suit if they acted in good faith and in a manner they reasonably believed to be in or not opposed to the best interests of the Corporation, provided that no indemnification shall be made in respect of any claim, issue, or matter as to which such person shall have been adjudged to be liable to the Corporation unless and only to the extent that the Court of Chancery of the State of Delaware or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper.

SECTION 3. Indemnification in Certain Cases. To the extent that a director, officer, employee, or agent of the Corporation has been successful on the merits or otherwise in defense of any action, suit, or proceeding referred to in Sections 1 and 2 of this Article VI, or in defense of any claim, issue, or matter therein, they may be indemnified against expenses (including attorneys' fees) actually and reasonably incurred by them in connection therewith.

SECTION 4. Procedure. Any indemnification under Sections 1 and 2 of this Article VI (unless ordered by a court) shall be made by the Corporation only as authorized in the specific case upon a determination that indemnification of the director, officer, employee or agent is proper in the circumstances because he has met the applicable standard of conduct set forth in such Sections 1 and 2. Such determination shall be made (a) by the Board of Directors by a majority vote of a quorum consisting of directors who were not parties to such action, suit or proceeding, or (b) if such a quorum is not obtainable, or, even if obtainable a quorum of disinterested directors so directs, by independent legal counsel in a written opinion, or (c) by the stockholders.

SECTION 5. Advances for Expenses. Expenses incurred in defending a civil or criminal action, suit or proceeding may be paid by the Corporation in advance of the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of the director, officer, employee or agent to repay such amount if it shall be ultimately determined that he is not entitled to be indemnified by the Corporation as authorized in this Article VI.

SECTION 6. Right Not Exclusive. The indemnification and advancement of expenses provided by, or granted pursuant to, the other subsections of this Article VI shall not be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled under any law, bylaw, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in his official capacity and as to action in another capacity while holding such office.

SECTION 7. Insurance. The Corporation shall have power to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against him and incurred by him in any such capacity, or arising out of his status as such, whether or not the Corporation would have the power to indemnify him against such liability under the provisions of this Article VI.

SECTION 8. Definition of Corporation. For the purposes of this Article VI, references to "the Corporation" include all constituent corporations absorbed in a consolidation or merger as well as the resulting or surviving corporation so that any person who is or was a director, officer, employee or agent of such a constituent corporation or is or was serving at the request of such constituent corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise shall stand in the same position under the provisions of this Article VI with respect to the resulting or surviving corporation as he would if he had served the resulting or surviving corporation in the same capacity.

SECTION 9. Survival of Rights. The indemnification and advancement of expenses provided by, or granted pursuant to this Article VI shall continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of the heirs, executors and administrators of such a person.

ARTICLE VI

CASH MANAGEMENT

SECTION 1. Cash Management Authority. The CEO of the Company is authorized to manage the cash and cash equivalents of the Company in a manner that maximizes the returns on the cash and cash equivalents consistent with the Company's risk management policies.

SECTION 2. Duties and Responsibilities of the CEO. The CEO shall have the following duties and responsibilities with respect to cash management: (a) To establish, implement, and monitor a cash management strategy that maximizes the returns on the cash and cash equivalents of the Company consistent with the Company's risk management policies. (b) To develop and maintain relationships with financial institutions and other market participants to ensure that the Company has access to a range of cash management products and services. (c) To monitor the performance of cash management products and services used by the Company. (d) To ensure that cash management activities comply with applicable laws and regulations.

ARTICLE VII

GENERAL PROVISIONS

SECTION 1. Dividends. Subject to the provisions of statute and the Certificate of Incorporation, dividends upon the shares of capital stock of the Corporation may be declared at the sole discretion of the President or Chief Executive Officer of the Corporation. No action or approval of the Board of Directors shall be required to declare or authorize such dividends. Dividends may be paid in cash, in property or in shares of stock of the Corporation, unless otherwise provided by statute or the Certificate of Incorporation.

SECTION 2. Reserves. Before payment of any dividend, there may be set aside out of any funds of the Corporation available for dividends such sum or sums as the President or Chief Executive Officer may, from time to time, in their sole and absolute discretion, determine appropriate as a reserve or reserves. These reserves may be created for any corporate purpose, including but not limited to meeting contingencies, equalizing dividends, repairing or maintaining property, funding strategic initiatives, or any other use deemed conducive to the interests of the Corporation. The President or Chief Executive Officer shall have the sole authority to modify, reallocate, or abolish any such reserves at any time and in any manner in which they were created. No approval or ratification by the Board of Directors shall be required for any such action.

SECTION 2A. Executive Discretion Over Capital Allocation. Notwithstanding any other provision in these bylaws, the President or Chief Executive Officer shall have exclusive authority to manage and allocate the Corporation's retained earnings, cash reserves, and other capital resources. This includes, but is not limited to, the authority to: (a) Declare, defer, or decline dividends or other capital distributions; (b) Establish, modify, or eliminate reserves; (c) Allocate funds to new or ongoing business operations, investments, or subsidiaries; and (d) Reinvest or retain proceeds from asset sales or other liquidity events. These actions may be taken without the need for approval, ratification, or consultation with the Board of Directors or stockholders, and shall be subject only to applicable statutory requirements and the Certificate of Incorporation.

SECTION 3. Seal. The seal of the Corporation shall be in such form as shall be approved by the Board of Directors.

SECTION 4. Fiscal Year. The fiscal year of the Corporation shall be fixed, and once fixed, may thereafter be changed, by resolution of the Board of Directors.

SECTION 5. Check, Notes, Drafts, Etc. All checks, notes, drafts or other orders for the payment of money of the Corporation shall be signed, endorsed or accepted in the name of the Corporation by such officer, officers, person or persons as from time to time may be designated by the Board of Directors or by an officer or officers authorized by the Board of Directors to make such designation.

SECTION 6. Compensation and Benefit Arrangements. The Chief Executive Officer (CEO) shall have the authority to approve and implement compensation and benefit arrangements for the Corporation, as deemed appropriate, without requiring additional board approval. Such actions shall comply with applicable legal and regulatory requirements, and the CEO may engage external advisors as necessary.

SECTION 7. Execution of Contracts, Deeds, Etc. The Board of Directors may authorize any officer or officers, agent or agents, in the name and on behalf of the Corporation to enter into or execute and deliver any and all deeds, bonds, mortgages, contracts and other obligations or instruments, and such authority may be general or confined to specific instances.

SECTION 8. Voting of Stock in Other Corporations. Unless otherwise provided by resolution of the Board of Directors, the Chairman of the Board or the President, from time to time, may (or may appoint one or more attorneys or agents to) cast the votes which the Corporation may be entitled to cast as a shareholder or otherwise in any other corporation, any of whose shares or securities may be held by the Corporation, at meetings of the holders of the shares or other securities of such other corporation. In the event one or more attorneys or agents are appointed, the Chairman of the Board or the President may instruct the person or persons so appointed as to the manner of casting such votes or giving such consent. The Chairman of the Board or the President may, or may instruct the attorneys or agents appointed to, execute or cause to be executed in the name and on behalf of the Corporation and under its seal or otherwise, such written proxies, consents, waivers or other instruments as may be necessary or proper in the circumstances.

ARTICLE VIII

AMENDMENTS

These bylaws may be amended, repealed, or new bylaws adopted at the sole discretion of the CEO or President, at any time they deem fit. Any amendment, repeal, or adoption of new bylaws proposed by the Board of Directors is subject to an additional vote, required by the bylaws, by the approval of the holders of a majority of the voting power of the issued and outstanding stock of the Corporation or alternatively, by the CEO and President.